T900607-sodium intravenous

SUSPENDED · PHASE2 · Gastric Cancer, Esophageal Neoplasms

Unknown stopping reason

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.